Skip to main content
Erschienen in: Journal of Clinical Immunology 6/2011

01.12.2011

A Reappraisal of Immunoglobulin Variable Gene Primers and Its Impact on Assessing Clonal Relationships Between PB B Cells and BM Plasma Cells in AL Amyloidosis

verfasst von: Nagaaki Katoh, Tanya L. Poshusta, Michelle K. Manske, Angela Dispenzieri, Morie A. Gertz, Roshini S. Abraham, Marina Ramirez-Alvarado

Erschienen in: Journal of Clinical Immunology | Ausgabe 6/2011

Einloggen, um Zugang zu erhalten

Abstract

Monoclonal tumor plasma cells as well as non-terminally differentiated B cells having a clonal relationship to the tumor cells have been detected in the peripheral blood (PB) of some multiple myeloma (MM) patients but rarely in light chain (primary systemic) amyloidosis (AL) patients. Previously, our group found these peripheral clonotypic B cells in three AL patients. Here, we report detailed analysis of a larger cohort of AL patients to validate the prior findings and to investigate the effect of this cell population on clinical outcome. Fourteen AL patients were selected from a clinical prospective trial, and the relationship between immunoglobulin light chain variable gene (VL) representation in PB B cells and the clonal population in the bone marrow (BM) was investigated. A clonal relationship was not detected, and the present study provides important insights into the disparity with the earlier data, including clinical history of the patients and methodological analysis.
Anhänge
Nur mit Berechtigung zugänglich
Literatur
1.
Zurück zum Zitat Gertz MA, Kyle RA. Primary systemic amyloidosis—a diagnostic primer. Mayo Clin Proc. 1989;64:1505–19. PubMed Gertz MA, Kyle RA. Primary systemic amyloidosis—a diagnostic primer. Mayo Clin Proc. 1989;64:1505–19. PubMed
2.
Zurück zum Zitat Gertz MA, Lacy MQ, Dispenzieri A. Amyloidosis. Hematol Oncol Clin North Am. 1999;13:1211–33. PubMedCrossRef Gertz MA, Lacy MQ, Dispenzieri A. Amyloidosis. Hematol Oncol Clin North Am. 1999;13:1211–33. PubMedCrossRef
3.
Zurück zum Zitat Kyle RA, Greipp PR. Amyloidosis (AL). Clinical and laboratory features in 229 cases. Mayo Clin Proc. 1983;58:665–83. PubMed Kyle RA, Greipp PR. Amyloidosis (AL). Clinical and laboratory features in 229 cases. Mayo Clin Proc. 1983;58:665–83. PubMed
4.
Zurück zum Zitat Kyle RA, Gertz MA. Primary systemic amyloidosis: clinical and laboratory features in 474 cases. Semin Hematol. 1995;32:45–59. PubMed Kyle RA, Gertz MA. Primary systemic amyloidosis: clinical and laboratory features in 474 cases. Semin Hematol. 1995;32:45–59. PubMed
5.
Zurück zum Zitat Kumar SK, Gertz MA, Lacy MQ, Dingli D, Hayman SR, Buadi FK, et al. Recent improvements in survival in primary systemic amyloidosis and the importance of an early mortality risk score. Mayo Clin Proc. 2011;86:12–8. PubMedCrossRef Kumar SK, Gertz MA, Lacy MQ, Dingli D, Hayman SR, Buadi FK, et al. Recent improvements in survival in primary systemic amyloidosis and the importance of an early mortality risk score. Mayo Clin Proc. 2011;86:12–8. PubMedCrossRef
6.
Zurück zum Zitat Kumar SK, Rajkumar SV, Dispenzieri A, Lacy MQ, Hayman SR, Buadi FK, et al. Improved survival in multiple myeloma and the impact of novel therapies. Blood. 2008;111:2516–20. PubMedCrossRef Kumar SK, Rajkumar SV, Dispenzieri A, Lacy MQ, Hayman SR, Buadi FK, et al. Improved survival in multiple myeloma and the impact of novel therapies. Blood. 2008;111:2516–20. PubMedCrossRef
7.
Zurück zum Zitat Billadeau D, Quam L, Thomas W, Kay N, Greipp P, Kyle R, et al. Detection and quantitation of malignant cells in the peripheral blood of multiple myeloma patients. Blood. 1992;80:1818–24. PubMed Billadeau D, Quam L, Thomas W, Kay N, Greipp P, Kyle R, et al. Detection and quantitation of malignant cells in the peripheral blood of multiple myeloma patients. Blood. 1992;80:1818–24. PubMed
8.
Zurück zum Zitat Billadeau D, Van Ness B, Kimlinger T, Kyle RA, Therneau TM, Greipp PR, et al. Clonal circulating cells are common in plasma cell proliferative disorders: a comparison of monoclonal gammopathy of undetermined significance, smoldering multiple myeloma, and active myeloma. Blood. 1996;88:289–96. PubMed Billadeau D, Van Ness B, Kimlinger T, Kyle RA, Therneau TM, Greipp PR, et al. Clonal circulating cells are common in plasma cell proliferative disorders: a comparison of monoclonal gammopathy of undetermined significance, smoldering multiple myeloma, and active myeloma. Blood. 1996;88:289–96. PubMed
9.
Zurück zum Zitat Rawstron AC, Owen RG, Davies FE, Johnson RJ, Jones RA, Richards SJ, et al. Circulating plasma cells in multiple myeloma: characterization and correlation with disease stage. Br J Haematol. 1997;97:46–55. PubMedCrossRef Rawstron AC, Owen RG, Davies FE, Johnson RJ, Jones RA, Richards SJ, et al. Circulating plasma cells in multiple myeloma: characterization and correlation with disease stage. Br J Haematol. 1997;97:46–55. PubMedCrossRef
10.
Zurück zum Zitat Witzig TE, Dhodapkar MV, Kyle RA, Greipp PR. Quantitation of circulating peripheral blood plasma cells and their relationship to disease activity in patients with multiple myeloma. Cancer. 1993;72:108–13. PubMedCrossRef Witzig TE, Dhodapkar MV, Kyle RA, Greipp PR. Quantitation of circulating peripheral blood plasma cells and their relationship to disease activity in patients with multiple myeloma. Cancer. 1993;72:108–13. PubMedCrossRef
11.
Zurück zum Zitat Witzig TE. Detection of malignant cells in the peripheral blood of patients with multiple myeloma: clinical implications and research applications. Mayo Clin Proc. 1994;69:903–7. PubMed Witzig TE. Detection of malignant cells in the peripheral blood of patients with multiple myeloma: clinical implications and research applications. Mayo Clin Proc. 1994;69:903–7. PubMed
12.
Zurück zum Zitat Witzig TE, Gertz MA, Pineda AA, Kyle RA, Greipp PR. Detection of monoclonal plasma cells in the peripheral blood stem cell harvests of patients with multiple myeloma. Br J Haematol. 1995;89:640–2. PubMedCrossRef Witzig TE, Gertz MA, Pineda AA, Kyle RA, Greipp PR. Detection of monoclonal plasma cells in the peripheral blood stem cell harvests of patients with multiple myeloma. Br J Haematol. 1995;89:640–2. PubMedCrossRef
13.
Zurück zum Zitat Witzig TE, Kimlinger TK, Ahmann GJ, Katzmann JA, Greipp PR. Detection of myeloma cells in the peripheral blood by flow cytometry. Cytometry. 1996;26:113–20. PubMedCrossRef Witzig TE, Kimlinger TK, Ahmann GJ, Katzmann JA, Greipp PR. Detection of myeloma cells in the peripheral blood by flow cytometry. Cytometry. 1996;26:113–20. PubMedCrossRef
14.
Zurück zum Zitat Witzig TE, Gertz MA, Lust JA, Kyle RA, Greipp PR. Serial studies of peripheral blood myeloma cells in patients with multiple myeloma: when is the optimal time for stem cell harvest? Leuk Lymphoma. 1995;19:417–22. PubMedCrossRef Witzig TE, Gertz MA, Lust JA, Kyle RA, Greipp PR. Serial studies of peripheral blood myeloma cells in patients with multiple myeloma: when is the optimal time for stem cell harvest? Leuk Lymphoma. 1995;19:417–22. PubMedCrossRef
15.
Zurück zum Zitat Rawstron AC, Davies FE, DasGupta R, Ashcroft AJ, Patmore R, Drayson MT, et al. Flow cytometric disease monitoring in multiple myeloma: the relationship between normal and neoplastic plasma cells predicts outcome after transplantation. Blood. 2002;100:3095–100. PubMedCrossRef Rawstron AC, Davies FE, DasGupta R, Ashcroft AJ, Patmore R, Drayson MT, et al. Flow cytometric disease monitoring in multiple myeloma: the relationship between normal and neoplastic plasma cells predicts outcome after transplantation. Blood. 2002;100:3095–100. PubMedCrossRef
16.
Zurück zum Zitat Gertz MA, Witzig TE, Pineda AA, Greipp PR, Kyle RA, Litzow MR. Monoclonal plasma cells in the blood stem cell harvest from patients with multiple myeloma are associated with shortened relapse-free survival after transplantation. Bone Marrow Transplant. 1997;19:337–42. PubMedCrossRef Gertz MA, Witzig TE, Pineda AA, Greipp PR, Kyle RA, Litzow MR. Monoclonal plasma cells in the blood stem cell harvest from patients with multiple myeloma are associated with shortened relapse-free survival after transplantation. Bone Marrow Transplant. 1997;19:337–42. PubMedCrossRef
17.
Zurück zum Zitat Comenzo RL, Michelle D, LeBlanc M, Wally J, Zhang Y, Kica G, et al. Mobilized CD34+ cells selected as autografts in patients with primary light-chain amyloidosis: rationale and application. Transfusion. 1998;38:60–9 [see comment]. PubMedCrossRef Comenzo RL, Michelle D, LeBlanc M, Wally J, Zhang Y, Kica G, et al. Mobilized CD34+ cells selected as autografts in patients with primary light-chain amyloidosis: rationale and application. Transfusion. 1998;38:60–9 [see comment]. PubMedCrossRef
18.
Zurück zum Zitat Levy Y, Schmitt C, Tsapis A, Brouet JC, Fermand JP. Phenotype and immunoglobulin gene configuration of blood B cells from patients with multiple myeloma. Clin Exp Immunol. 1991;84:435–9. PubMed Levy Y, Schmitt C, Tsapis A, Brouet JC, Fermand JP. Phenotype and immunoglobulin gene configuration of blood B cells from patients with multiple myeloma. Clin Exp Immunol. 1991;84:435–9. PubMed
19.
Zurück zum Zitat Guikema JE, Vellenga E, Veeneman JM, Hovenga S, Bakkus MH, Klip H, et al. Multiple myeloma related cells in patients undergoing autologous peripheral blood stem cell transplantation. Br J Haematol. 1999;104:748–54. PubMedCrossRef Guikema JE, Vellenga E, Veeneman JM, Hovenga S, Bakkus MH, Klip H, et al. Multiple myeloma related cells in patients undergoing autologous peripheral blood stem cell transplantation. Br J Haematol. 1999;104:748–54. PubMedCrossRef
20.
Zurück zum Zitat Billadeau D, Ahmann G, Greipp P, Van Ness B. The bone marrow of multiple myeloma patients contains B cell populations at different stages of differentiation that are clonally related to the malignant plasma cell. J Exp Med. 1993;178:1023–31. PubMedCrossRef Billadeau D, Ahmann G, Greipp P, Van Ness B. The bone marrow of multiple myeloma patients contains B cell populations at different stages of differentiation that are clonally related to the malignant plasma cell. J Exp Med. 1993;178:1023–31. PubMedCrossRef
21.
Zurück zum Zitat Pilarski LM, Masellis-Smith A, Szczepek A, Mant MJ, Belch AR. Circulating clonotypic B cells in the biology of multiple myeloma: speculations on the origin of myeloma. Leukemia Lymphoma. 1996;22:375–83. PubMedCrossRef Pilarski LM, Masellis-Smith A, Szczepek A, Mant MJ, Belch AR. Circulating clonotypic B cells in the biology of multiple myeloma: speculations on the origin of myeloma. Leukemia Lymphoma. 1996;22:375–83. PubMedCrossRef
22.
Zurück zum Zitat Mellstedt H, Hammarstrom S, Holm G. Monoclonal lymphocyte population in human plasma cell myeloma. Clin Exp Immunol. 1974;17:371–84. PubMed Mellstedt H, Hammarstrom S, Holm G. Monoclonal lymphocyte population in human plasma cell myeloma. Clin Exp Immunol. 1974;17:371–84. PubMed
23.
Zurück zum Zitat Epstein J. Myeloma stem cell phenotype. Implications for treatment. Hematol-Oncol Clin North Am. 1997;11:43–9. PubMedCrossRef Epstein J. Myeloma stem cell phenotype. Implications for treatment. Hematol-Oncol Clin North Am. 1997;11:43–9. PubMedCrossRef
24.
Zurück zum Zitat Berenson JR, Vescio RA, Said J. Multiple myeloma: the cells of origin—a two-way street. Leukemia. 1998;12:121–7. PubMedCrossRef Berenson JR, Vescio RA, Said J. Multiple myeloma: the cells of origin—a two-way street. Leukemia. 1998;12:121–7. PubMedCrossRef
25.
Zurück zum Zitat Mitterer M, Oduncu F, Lanthaler AJ, Drexler E, Amaddii G, Fabris P, et al. The relationship between monoclonal myeloma precursor B cells in the peripheral blood stem cell harvests and the clinical response of multiple myeloma patients. Br J Haematol. 1999;106:737–43 [see comment]. PubMedCrossRef Mitterer M, Oduncu F, Lanthaler AJ, Drexler E, Amaddii G, Fabris P, et al. The relationship between monoclonal myeloma precursor B cells in the peripheral blood stem cell harvests and the clinical response of multiple myeloma patients. Br J Haematol. 1999;106:737–43 [see comment]. PubMedCrossRef
26.
Zurück zum Zitat Davies FE, Rawstron AC, Owen RG, Morgan GJ. Controversies surrounding the clonogenic origin of multiple myeloma. Br J Haematol. 2000;110:240–1 [comment]. PubMedCrossRef Davies FE, Rawstron AC, Owen RG, Morgan GJ. Controversies surrounding the clonogenic origin of multiple myeloma. Br J Haematol. 2000;110:240–1 [comment]. PubMedCrossRef
27.
Zurück zum Zitat Rawstron AC, Barrans SL, Blythe D, English A, Richards SJ, Fenton JA, et al. In multiple myeloma, only a single stage of neoplastic plasma cell differentiation can be identified by VLA-5 and CD45 expression. Br J Haematol. 2001;113:794–802 [see comment]. PubMedCrossRef Rawstron AC, Barrans SL, Blythe D, English A, Richards SJ, Fenton JA, et al. In multiple myeloma, only a single stage of neoplastic plasma cell differentiation can be identified by VLA-5 and CD45 expression. Br J Haematol. 2001;113:794–802 [see comment]. PubMedCrossRef
28.
Zurück zum Zitat Abraham RS, Manske MK, Zuckerman NS, Sohni A, Edelman H, Shahaf G, et al. Novel analysis of clonal diversification in blood B cell and bone marrow plasma cell clones in immunoglobulin light chain amyloidosis. J Clin Immunol. 2007;27:69–87. PubMedCrossRef Abraham RS, Manske MK, Zuckerman NS, Sohni A, Edelman H, Shahaf G, et al. Novel analysis of clonal diversification in blood B cell and bone marrow plasma cell clones in immunoglobulin light chain amyloidosis. J Clin Immunol. 2007;27:69–87. PubMedCrossRef
29.
Zurück zum Zitat Kuppers R et al. Weir’s handbook of experimental immunology. Malden: Blackwell Science; 1997. p. 206.1–4. Kuppers R et al. Weir’s handbook of experimental immunology. Malden: Blackwell Science; 1997. p. 206.1–4.
30.
Zurück zum Zitat Welschof M, Terness P, Kolbinger F, Zewe M, Dübel S, Dörsam H, et al. Amino acid sequence based PCR primers for amplification of rearranged human heavy and light chain immunoglobulin variable region genes. J Immunol Meth. 1995;179:203–14. CrossRef Welschof M, Terness P, Kolbinger F, Zewe M, Dübel S, Dörsam H, et al. Amino acid sequence based PCR primers for amplification of rearranged human heavy and light chain immunoglobulin variable region genes. J Immunol Meth. 1995;179:203–14. CrossRef
31.
Zurück zum Zitat Kawano MM, Huang N, Harada H, Harada Y, Sakai A, Tanaka H, et al. Identification of immature and mature myeloma cells in the bone marrow of human myelomas. Blood. 1993;82:564–70. PubMed Kawano MM, Huang N, Harada H, Harada Y, Sakai A, Tanaka H, et al. Identification of immature and mature myeloma cells in the bone marrow of human myelomas. Blood. 1993;82:564–70. PubMed
Metadaten
Titel
A Reappraisal of Immunoglobulin Variable Gene Primers and Its Impact on Assessing Clonal Relationships Between PB B Cells and BM Plasma Cells in AL Amyloidosis
verfasst von
Nagaaki Katoh
Tanya L. Poshusta
Michelle K. Manske
Angela Dispenzieri
Morie A. Gertz
Roshini S. Abraham
Marina Ramirez-Alvarado
Publikationsdatum
01.12.2011
Verlag
Springer US
Erschienen in
Journal of Clinical Immunology / Ausgabe 6/2011
Print ISSN: 0271-9142
Elektronische ISSN: 1573-2592
DOI
https://doi.org/10.1007/s10875-011-9582-y

Weitere Artikel der Ausgabe 6/2011

Journal of Clinical Immunology 6/2011 Zur Ausgabe

Update Innere Medizin

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.